Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Advanced Laboratory Medicine, |
RCV000852565 | SCV000995266 | uncertain significance | Brugada syndrome | 2019-02-16 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001305785 | SCV001495132 | uncertain significance | Dilated cardiomyopathy 1JJ | 2020-03-06 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has been observed in individual(s) with sudden unexplained death (PMID: 28986455). ClinVar contains an entry for this variant (Variation ID: 691713). This variant is present in population databases (rs782547342, ExAC 0.003%). This sequence change replaces serine with isoleucine at codon 448 of the LAMA4 protein (p.Ser448Ile). The serine residue is moderately conserved and there is a large physicochemical difference between serine and isoleucine. |
Fulgent Genetics, |
RCV001305785 | SCV002776478 | uncertain significance | Dilated cardiomyopathy 1JJ | 2021-11-22 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004693415 | SCV005189205 | uncertain significance | not provided | criteria provided, single submitter | not provided |